Bradley J. Monk

Shares of OXiGENE Inc (NASDAQ: OXGN), a nano-cap biopharmaceutical company that focuses on the development of vascular disrupting agents for the treatment of cancer, surged higher by more than 65 percent early Tuesday morning. Investors and traders reacted to OXiGENE's announcement that the "...